Twenty-six studies (n=1008 participants) compared the visfatin level between nonobese PCOS patients and controls (Figure 4B), and there was significant heterogeneity among the studies (I2 = 96%; P<0.00001). This evidence concerns the gene NAMPT and polycystic ovary syndrome.